OJOG  Vol.5 No.9 , August 2015
Hyponeurotrophinemia in Serum of Women with Polycystic Ovary Syndrome as a Low Grade Chronic Inflammation
ABSTRACT
Introduction: This study aimed to discuss about neuroimmune-pathophysiology of polycystic ovary syndrome (PCOS). Nerve growth factor (NGF) as modulator of neuro-endocrine-immune (NEI) system plays a critical role in tissue survival and homeostasis maintenance. It is a strong marker for sympathetic nerve activity. Women with PCO have enhanced ovarian NGF production. Over the past few decades, PCOS has been discussed as a low grade chronic inflammatory disease. In this study, we investigated the neuromodulator role of serum NGF and inflammatory cytokines (IL-1α, β, 17A and TNF-α) in women with PCOS. Material and Methods: 171 patients were investigated in two groups: study (n = 85 PCO) and control (n = 86). Serum levels of NGF-α and interleukins IL-1α, IL-1β, IL-17A and TNFα were determined in both groups by ELISA kit. Results: Data of this study showed that the level of NGF-α and IL-17A in serum of PCO women were lower than control group (p < 0.001). The serum levels of IL-1α, IL-1β were higher than control group in PCO women (p < 0.001). Conclusion: Probably inflammatory background in PCOS is the main cause of increased serum levels of IL-1α, IL-1β. Reduction of IL-17A and NGF in serum of PCO patients might be under the direct influence of the hyperactivity of sympathetic nervous system (SNS).

Cite this paper
Zangeneh, F. , Bagheri, M. and Naghizadeh, M. (2015) Hyponeurotrophinemia in Serum of Women with Polycystic Ovary Syndrome as a Low Grade Chronic Inflammation. Open Journal of Obstetrics and Gynecology, 5, 459-469. doi: 10.4236/ojog.2015.59067.
References
[1]   Moran, L.J., Hutchison, S.K., Norman, R.J. and Teede, H.J. (2011) Lifestyle Changes in Women with Polycystic Ovary Syndrome. The Cochrane Database of Systematic Reviews, 162, CD007506.

[2]   Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome. Fertility and Sterility, 81, 19-25.

[3]   Lara, H.E., Ferruz, J.L., Luza, S., Bustamante, D.A., Borges, Y. and Ojeda, S.R. (1993) Activation of Ovarian Sympathetic Nerves in Polycistic Ovary Syndrome. Endocrinology, 133, 2690-2695.

[4]   Semenova, I. (1969) Adrenergic Innervation of the Ovaries in Stein-Leventhal Syndrome. Vestn Akad Med Nauk SSSR, 24, 58-62.

[5]   Heide, U., Pedal, I. and Spanel-Borowski, K. (2001) Increase in Nerve Fibers and Loss of Mast Cells in Polycystic and Postmenopausal Ovaries. Fertility and Sterility, 75, 1141-1147.

[6]   Lobo, R.A., Granger, L.R., Paul, W.L., Goebelsmann, U. and Mishell Jr., D.R. (1983) Psychological Stress and Increases in Urinary Norepinephrine Metabolites, Platelet Serotonin, and Adrenal Androgens in Women with Polycystic Ovary Syndrome. American Journal of Obstetrics & Gynecology, 145, 496-503.

[7]   Dissen, G.A., Garcia-Ruda, C. and Paredes, A. (2009) Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in Humans. Endocrinology, 150, 2906-2914.

[8]   Lara, H.E., Dissen, G.A., Leylon, V., Paredes, A., Fuenzalida, H., Fedler, J.L. and Ojeda, S.R. (2000) An Increased Intraovarian Synthesis of Nerve Growth Factor and Its Low Affinity Receptor Is a Principal Component of Steroid-Induced Polycystic Ovary in the Rat. Endocrinology, 141, 1059-1072.

[9]   Repaci, A., Gambineri, A. and Pasquali, R. (2011) The Role of Low-Grade Inflammation in the Polycystic Ovary Syndrome. Molecular and Cellular Endocrinology, 335, 30-41.

[10]   Fernandez-Real, J.M. and Ricart, W. (2003) Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome. Endocrine Reviews, 24, 278-301.

[11]   Escobar-Morreale, H.F., Luque-Ramirez, M. and San Millan, J.L. (2005) The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome. Endocrine Reviews, 26, 251-282.
http://dx.doi.org/10.1210/er.2004-0004

[12]   Reis, F.M., Cobellis, L., Luisi, S., Driul, L., Florio, P., Faletti, A. and Petraglia, F. (2000) Paracrine/Autocrine Control of Female Reproduction. Gynecological Endocrinology, 14, 464-475.
http://dx.doi.org/10.3109/09513590009167720

[13]   Dinarello, C.A. (1998) Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist. International Reviews of Immunology, 16, 457-499.
http://dx.doi.org/10.3109/08830189809043005

[14]   Smagin, G.N., Swiergiel, A.H. and Dunn, A.J. (1996) Peripheral Administration of Interleukin-1 Increases Extracellular Concentrations of Norepinephrine in Rat Hypothalamus: Comparison with Plasma Corticosterone. Psychoneuroendocrinology, 21, 83-93.
http://dx.doi.org/10.1016/0306-4530(95)00019-4

[15]   Chuluyan, H., Saphier, D., Rohn, W. and Dunn, A.J. (1992) Noradrenergic Innervation of the Hypothalamus Participates in the Adrenocortical Responses to Interleukin-1. Neuroendocrinology, 56, 106-111.
http://dx.doi.org/10.1159/000126215

[16]   Kolbus, A., Walch, K., Nagele, F., Wenzl, R., Unfried, G. and Huber, C.J. (2007) Interleukin-1 Alpha but Not Interleukin-1 Beta Gene Polymorphism Is Associated with Polycystic Ovary Syndrome. Journal of Reproductive Immunology, 73, 188-193.
http://dx.doi.org/10.1016/j.jri.2006.08.002

[17]   Chaldakov, G.N., Fiore, M., Stankulov, I.S., Manni, L., Hristova, M.G., Antonelli, A., Ghenev, P.I. and Aloe, L. (2004) Neurotrophin Presence in Human Coronary Atherosclerosis and Metabolic Syndrome: A Role for NGF and BDNF in Cardiovascular Disease? Progress in Brain Research, 146, 279-289.

[18]   Atsumi, T., Singh, R., Sabharwal, L., Bando, H., Meng, J., Arima, Y., Yamada, M., Harada, M., Jiang, J.J., Kamimura, D., Ogura, H., Hirano, T. and Murakami, M. (2014) Inflammation Amplifier, a New Paradigm in Cancer Biology. Cancer Research, 74, 8-14.
http://dx.doi.org/10.1158/0008-5472.CAN-13-2322

[19]   Chaves, R.N., Alves, A.M., Lima, L.F., Matos, H.M., Rodrigues, A.P. and Figueiredo, J.R. (2013) Role of Nerve Growth Factor (NGF) and Its Receptors in Folliculogenesis. Zygote, 21, 187-197.
http://dx.doi.org/10.1017/S0967199412000111

[20]   Dissen, G.A., Paredes, A., Romero, C., Dees, W.L. and Ojeda, S.R. (2004) Neural and Neurotrophic Control of Ovarian Development. In: Leung, P. and Adashi, E., Eds., the Ovary, 2nd Edition, Academic Press, San Diego, 3-23.

[21]   Dissen, G.A., Hill, D.F., Costa, M.E., Les Dees, C.W., Lara, H.E. and Ojeda, S.R. (1996) A Role for Trka Nerve Growth Factor Receptors in Mammalian Ovulation. Endocrinology, 137, 198-209.

[22]   Dissen, G.A., Parrott, J.A., Skinner, M.K., Hill, D.F., Costa, M.E. and Ojeda, S.R. (2000) Direct Effects of Nerve Growth Factor on Thecal Cells from Antral Ovarian Follicles. Endocrinology, 141, 4736-4750.

[23]   Dissen, G.A., Lara, H.E., Leyton, V., Paredes, A., Hill, D.F., Costa, M.E., Martinez-Serrano, A. and Ojeda, S.R. (2000) Intraovarian Excess of Nerve Growth Factor Increases Androgen Secretion and Disrupts Estrous Cyclicity in the Rat. Endocrinology, 141, 1073-1082.

[24]   Garcia-Rudaz, C., Mayerhofer, A., Ojeda, S.R. and Dissen, G.A. (2008) An Excessive Ovarian Production of Nerve Growth Factor (NGF) Facilitates the Development of Polycystic Ovarian Morphology in Mice and Is a Discernible Feature of Polycystic Ovarian Syndrome (PCOS) in Humans. Program of the 90th Annual Meeting of the Endocrine Society, San Francisco. (Abstract P483).

[25]   Gore-Langton, R.E. and Armstrong, D.T. (1994) Follicular Steroidogenesis and Its Control. In: Knobil, E. and Neill, J.D., Eds., the Physiology of Reproduction, 2nd Edition, Raven Press, Ltd., New York, 571-627.

[26]   Carr, M.J. and Undem, B.J. (2001) Inflammation-Induced Plasticity of the Afferent Innervation of the Airways. Environmental Health Perspectives, 109, 567-571.
http://dx.doi.org/10.1289/ehp.01109s4567

[27]   Bulló, M., Peeraully, M.R., Trayhurn, P., Folch, J. and Salas-Salvadó, J. (2007) Circulating Nerve Growth Factor Levels in Relation to Obesity and the Metabolic Syndrome in Women. European Journal of Endocrinology, 157, 303-310.
http://dx.doi.org/10.1530/EJE-06-0716

[28]   Zangeneh, F.Z., Mohammadi, A., Ejtemaeimehr, S.H., Naghizadeh, M.M. and Fatemeh, A. (2011) The Role of Opioid System and Its Interaction with Sympathetic Nervous System in the Processing of Polycystic Ovary Syndrome Modeling in Rat. Archives of Gynecology and Obstetrics, 283, 885-892.
http://dx.doi.org/10.1007/s00404-010-1776-7

[29]   Dissen, G.A. and Ojeda, S.R. (2004) Transgenic Expression of Nerve Growth Factor (NGF) Targeted to Ovarian Androgen-Producing Cells Delays Pubertal Development and Compromises Fertility. Program of the 86th Annual Meeting of the Endocrine Society, New Orleans, 212. (Abstract P242)

[30]   Stener-Victorin, E., Lundeberg, T., Waldenstrom, U., Manni, L., Aloe, L., Gunnarsson, S. and Janson, P.O. (2000) Effects of Electro-Acupuncture on Nerve Growth Factor in Rats with Experimentally Induced Polycystic Ovaries. Biology of Reproduction, 63, 1507-1513.

[31]   Edwards, R.H., Rutter, W.J. and Hanahan, D. (1989) Directed Expression of NGF to Pancreatic β Cells in Transgenic Mice Leads to Selective Hyperinnervation of the Islets. Cell, 58, 161-170.
http://dx.doi.org/10.1016/0092-8674(89)90412-1

[32]   Schmidt, R.E., Dorsey, D.A., Roth, K.A., Parvin, C.A., Hounsom, L. and Tomlinson, D.R. (1994) Effect of Streptozotocin-Induced Diabetes on NGF, p75(NTR) and TrkA Content of Prevertebral and Paravertebral Rat Sympathetic Ganglia. Brain Research, 867, 149-156.
http://dx.doi.org/10.1016/S0006-8993(00)02281-2

[33]   Lee, K.F., Bachman, K., Landis, S. and Jaenisch, R. (1994) Dependence on p75 for Innervation of Some Sympathetic Targets. Science, 263, 1447-1449.
http://dx.doi.org/10.1126/science.8128229

[34]   Cowen, T. and Gavazzi, I. (2005) Plasticity in Adult and Ageing Sympathetic Neurons. Progress in Neurobiology, 54, 249-288.
http://dx.doi.org/10.1016/S0301-0082(97)00071-3

[35]   Lansdown, A.L. and Rees, D.A. (2012) The Sympathetic Nervous System in Polycystic Ovary Syndrome: A Novel Therapeutic Target? Clinical endocrinology (Oxford), 77, 791-801.
http://dx.doi.org/10.1111/cen.12003

[36]   Manni, L., Nikolova, V., Vyagova, D., Chaldakov, G.N. and Aloe, L. (2004) Reduced Plasma Levels of NGF and BDNF in Patients with Acute Coronary Syndromes. International Journal of Cardiology, 102, 169-171.
http://dx.doi.org/10.1016/j.ijcard.2004.10.041

[37]   Stener-Victorin, E., Lundeberg, T., Cajander, S., Aloe, L., Manni, L., Waldenstrom, U. and Janson, P.O. (2003) Steroid-Induced Polycystic Ovaries in Rats: Effect of Electro-Acupuncture on Concentrations of Endothelin-1 and Nerve Growth Factor (NGF), and Expression of NGF mRNA in the Ovaries, the Adrenal Glands, and the Central Nervous System. Reproductive Biology and Endocrinology, 1, 33-40.
http://dx.doi.org/10.1186/1477-7827-1-33

[38]   Manni, L., Holmang, A., Lundeberg, T., Aloe, L., Stener-Victorin, E. (2005) Ovarian Expression of Alpha (1)- and Beta (2)-Adrenoceptors and p75 Neurotrophin Receptors in Rats with Steroid-Induced Polycystic Ovaries. Autonomic Neuroscience, 118, 79-87.
http://dx.doi.org/10.1016/j.autneu.2005.01.004

[39]   Jones, P.P., Davy, K.P., Alexander, S. and Seals, D.R. (1997) Age-Related Increase in Muscle Sympathetic Nerve Activity Is Associated with Abdominal Adiposity. American Journal of Physiology, Endocrinology and Metabolism, 272, E976-E980.

[40]   Kim, J.J. and Choi, Y.M. (2013) Dyslipidemia in Women with Polycystic Ovary Syndrome. Obstetrics & Gynecology Science, 56, 137-142.
http://dx.doi.org/10.5468/ogs.2013.56.3.137

[41]   Celik, C., Tasdemir, N., Abali, R., Bastu, E. and Yilmaz, M. (2014) Progression to Impaired Glucose Tolerance or Type 2 Diabetes Mellitus in Polycystic Ovary Syndrome: A Controlled Follow-Up Study. Fertility and Sterility, 101, 1123-1128.

[42]   Kaaja, R.J. and Poyhonen-Alho, M.K. (2006) Insulin Resistance and Sympathetic Overactivity in Women. Journal of Hypertension, 24, 131-141.
http://dx.doi.org/10.1097/01.hjh.0000194121.19851.e5

[43]   Chaldakov, G.N., Fiore, M., Hristova, M.G. and Aloe. L, (2003) Metabotrophic Potential of Neurotrophins: Implication in Obesity and Related Diseases? Medical Science Monitor, 9, HY19-HY21.

[44]   Chaldakov, G.N., Stankulov, I.S., Fiore, M., Ghenev, P.I. and Aloe, L. (2001) Nerve Growth Factor Levels and Mast Cells Distribution in Human Coronary Atherosclerosis. Atherosclerosis, 159, 57-66.
http://dx.doi.org/10.1016/S0021-9150(01)00488-9

[45]   Haefeli, W.E., Bargetzi, M.J., Starnes, H.F., Blaschke, T.F. and Hoffman, B.B. (1993) Evidence for Activation of the Sympathetic Nervous System by Recombinant Human Interleukin-1 Beta in Humans. Journal of Immunotherapy with Emphasis on Tumor Immunology, 13, 136-140.
http://dx.doi.org/10.1097/00002371-199302000-00009

[46]   Luther, J.A. and Birren, S.J. (2009) p75 and TrkA Signaling Regulates Sympathetic Neuronal Firing Patterns via Differential Modulation of Voltage-Gated Currents. The Journal of Neuroscience, 29, 5411-5424.
http://dx.doi.org/10.1523/JNEUROSCI.3503-08.2009

[47]   Apfel, S. (1999) Neurotrophic Factors and Diabetic Peripheral Neuropathy. European Neurology, 41, 27-34.
http://dx.doi.org/10.1159/000052077

[48]   Chaldakov, G.N., Tonchev, A.B. and Manni, L. (2007) Brain-Derived Neurotrophic Factor (BDNF) and Type 2 Diabetes. Diabetologia, 50, 431-438.

[49]   Hristova, M.G. (2013) Metabolic Syndrome—from the Neurotrophic Hypothesis to A Theory. Medical Hypotheses, 81, 627-634.
http://dx.doi.org/10.1016/j.mehy.2013.07.018

[50]   Zangeneh, F.Z., Abdollahi, A., Tavassoli, P. and Naghizadeh, M.M. (2011) The Effect of Cold Stress on Polycystic Ovary Syndrome in Rat: Before and during Modeling. Archives of Gynecology, 284, 651-657.
http://dx.doi.org/10.1007/s00404-010-1711-y

[51]   Zangeneh, F.Z., Naghizadeh, M.M., Abdollahi, A. and Abedinia, N. (2015) Opioid System (β-Endorphin) and Stress Hormones Profiling in Women with Polycystic Ovary Syndrome. Annual Research & Review in Biology, 5, 409-418.
http://dx.doi.org/10.9734/ARRB/2015/12932

[52]   Alleva, E., Petruzzi, S., Cirulli, F. and Aloe, L. (1996) NGF Regulatory Role in Stress and Coping of Rodents and Humans. Pharmacology Biochemistry and Behavior, 54, 65-72.
http://dx.doi.org/10.1016/0091-3057(95)02111-6

[53]   Aisa, B., Gil-Bea, F.J., Marcos, B., Tordera, R., Lasheras, B., Del Rio, J. and Ramirez, M.J. (2009) Neonatal Stress Affects Vulnerability of Cholinergic Neurons and Cognition in the Rat: Involvement of the HPA Axis. Psychoneuroendocrinology, 34, 1495-1505.
http://dx.doi.org/10.1016/j.psyneuen.2009.05.003

[54]   Cirulli, F. and Alleva, E. (2009) The NGF Saga from Animal Models of Psychosocial Stress to Stress-Related psychopathology. Frontiers in Neuroendocrinology, 30, 379-395.
http://dx.doi.org/10.1016/j.yfrne.2009.05.002

[55]   Aloe, L., Alleva, E. and Fiore, M. (2002) Stress and Nerve Growth Factor: Findings in Animal Models and Humans. Pharmacology Biochemistry and Behavior, 73, 159-166.
http://dx.doi.org/10.1016/S0091-3057(02)00757-8

[56]   Zangeneh, F.Z., Jafarabadi, M., Naghizadeh, M.M., Abedinia, N. and Haghollahi, F. (2012) Psychological Distress in Women with Polycystic Ovary Syndrome from Imam Khomeini Hospital, Tehran. Journal of Reproduction & Infertility, 13, 111-115.

[57]   Veltman-Verhulst, S.M., Boivin, J., Eijkemans, M.J. and Fauser, B.J. (2012) Emotional Distress Is a Common Risk in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of 28 Studies. Human Reproduction Update, 18, 638-651.
http://dx.doi.org/10.1093/humupd/dms029

 
 
Top